125
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Expression of activation-induced cytidine deaminase splicing variants in patients with ankylosing spondylitis

, , , &
Pages 435-440 | Received 31 Jul 2017, Accepted 24 Sep 2017, Published online: 29 Sep 2017

References

  • Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996;85:311–318.
  • Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340–350.
  • McGonagle D, Marzo-Ortega H, O'Connor P, et al. Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis. 2002;61:534–537.
  • Appel H, Kuhne M, Spiekermann S, et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum. 2006;54:2845–2851.
  • Lin Q, Gu JR, Li TW, et al. Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. Chin Med J. 2009;122:1784–1789.
  • Schwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987;166:173–181.
  • Lakomek HJ, Plomann M, Specker C, et al. Ankylosing spondylitis: an autoimmune disease?. Ann Rheum Dis. 1991;50:776–781.
  • Wright C, Sibani S, Trudgian D, et al. Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics. 2012;11:M9 00384.
  • Song IH, Heldmann F, Rudwaleit M, et al. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum. 2010;62:1290–1297.
  • Voswinkel J, Weisgerber K, Pfreundschuh M, et al. B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res. 2001;3:189–195.
  • Kim YJ, Kim NY, Lee MK, et al. Overexpression and unique rearrangement of VH2 transcripts in immunoglobulin variable heavy chain genes in ankylosing spondylitis patients. Exp Mol Med. 2010;42:319–326.
  • Sheen DH, Kim JY, Lee SY, et al. Restoration of overexpressed variable heavy chain 2 transcripts with tumor necrosis factor inhibitors in ankylosing spondylitis. J Rheumatol. 2014;41:613–614.
  • Park SR. Activation-induced cytidine deaminase in B cell immunity and cancers. Immune Netw. 2012;12:230–239.
  • McCarthy H, Wierda WG, Barron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood. 2003;101:4903–4908.
  • Wu X, Darce JR, Chang SK, et al. Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells. Blood. 2008;112:4675–4682.
  • van Maldegem F, Jibodh RA, van Dijk R, et al. Activation-induced cytidine deaminase splice variants are defective because of the lack of structural support for the catalytic site. J Immunol. 2010;184:2487–2491.
  • Iacobucci I, Lonetti A, Messa F, et al. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients. Leukemia. 2010;24:66–73.
  • Zan H, Zhang J, Ardeshna S, et al. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity. 2009;42:89–103.
  • Hsu HC, Wu Y, Yang P, et al. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol. 2007;178:5357–5365.
  • Xu X, Hsu HC, Chen J, et al. Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis. Scand J Immunol. 2009;70:309–316.
  • Zan H, Komori A, Li Z, et al. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity. 2001;14:643–653.
  • Zeng X, Winter DB, Kasmer C, et al. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol. 2001;2:537–541.
  • Zan H, Shima N, Xu Z, et al. The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J. 2005;24:3757–3769.
  • Xu Z, Fulop Z, Zhong Y, et al. DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation. Ann N Y Acad Sci. 2005;1050:146–162.
  • Casali P, Pal Z, Xu Z, et al. DNA repair in antibody somatic hypermutation. Trends Immunol. 2006;27:313–321.
  • Pang SW, Davis JC. Clinical aspects of ankylosing spondylitis. In: Weisman MH, Reveille JD, Van der Heijde D, editors. Ankylosing spondylitis and the spondyloarthopathies. 1st ed. Philadelpia: Mosby; 2006. p. 65–74.
  • Niu XY, Zhang HY, Liu YJ, et al. Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis. Life Sci. 2013;93:687–692.
  • Cantaert T, Doorenspleet ME, Francosalinas G, et al. Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis. Arthritis Rheum. 2012;64:1859–1868.
  • Kim YG, Sohn DH, Zhao X, et al. Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. Arthritis Rheumatol. 2014;66:2793–2803.
  • Lopez-Larrea C, Gonzalez S, Martinez-Borra J. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today. 1998;4:540–549.
  • Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum. 1995;38:1547–1554.
  • Ebringer A. Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin North Am. 1992;18:105–121.
  • Stone MA, Payne U, Schentag C, et al. Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis. Rheumatology. 2004;43:148–155.
  • Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361–371.
  • Endo Y, Marusawa H, Chiba T. Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers. J Gastroenterol. 2011;46(Suppl 1):6–10.
  • Dorner T, Farner NL, Lipsky PE. Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J Immunol. 1999;163:1027–1036.
  • Chu WM. Tumor necrosis factor. Cancer Lett. 2013;328:222–225.
  • McDonald JP, Rapic-Otrin V, Epstein JA, et al. Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. Genomics. 1999;60:20–30.
  • Tissier A, Frank EG, McDonald JP, et al. Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase iota. EMBO J. 2000;19:5259–5266.
  • Faili A, Aoufouchi S, Flatter E, et al. Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota. Nature. 2002;419:944–947.
  • Kanao R, Yokoi M, Ohkumo T, et al. UV-induced mutations in epidermal cells of mice defective in DNA polymerase η and/or ι. DNA Repair. 2015;29:139–146.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.